Related Article

This Perspective refers to the following article:
A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions
Lori J. Wirth, Jeffrey F. Krane, Yi Li, Megan Othus, Amy E. Moran, David M. Dorfman, Charles M. Norris, Jr, Laura Goguen, Marshall R. Posner, Robert I. Haddad and Monica M. Bertagnolli